Meetings

First AMiCI Working Group meetings in Heerlen – A great success!

November 16-17 ’ 2016 the first WG meetings of our COST AMiCI Action took place at the premises of Zuyd University of Applied Sciences in Heerlen, the Netherlands. Zuyd is the

Read More...

News

Twenty-nine countries join forces to prevent healthcare associated infectious diseases

Over sixty universities, research institutes and companies from twenty-nine European countries will jointly study the impact of applying antimicrobial (nano-)coatings on decreasing the spread of infections. The beneficial aspects of

Read More...

News

Welcome at the AMiCI website!

AMiCI is the acronym of AntiMicrobial Coating Innovations. It is a consortium which was initiated by researchers at the Zuyd University of Applied Sciences in the Netherlands in 2012. AMiCI

Read More...

News

Research Coordination and Capacity-building Objectives

The main objective of AMiCI action is to develop, structure, coordinate and maintain a long-term, flexible and open European network in the field of AMC in healthcare. The scientific field

Read More...

Meetings

First official AMiCI conference to be held in Heerlen (the Netherlands) 16-17 November’16

AMiCI WG meeting 16-17 November ’16 in Heerlen (the Netherlands) has been discussed and announced during the meeting in Porto. The draft program of the conference would include: Welcome words

Read More...

News

Rising threats from AntiMicriobial Resistance

Many efforts to reduce AMR have been initiated, are ongoing and have been concluded. However many of these have been proven to be only partially sufficient. In order to succeed,

Read More...

News

AMiCI Action in Relation to Existing Efforts at European Level

Coordination of the best European research resources and capabilities will form the necessary critical mass and develop the most advanced scientific approaches to tackle AMR, reversing its increasing trend, and

Read More...

News

The state-of-the-art in AMC

Novel antibiotic drugs are scarce and increasing resistance against antimicrobial drugs is established. Innovations that tackle rising and prominent threats in healthcare are demanded. Preventive innovations are needed to minimize

Read More...